Immunoglobulin E as a Biomarker in Asthma.
Asthma is a chronic disease that affects children and adults with significant morbidity and mortality. It is multifactorial, with genetic and environmental factors affecting the overall course of the disease. Both specific and total immunoglobulin (Ig)E can be used in specific phenotypes such as allergic asthma. Using IgE as a biomarker for asthma provides a target for management and treatment. Biotherapeutics continue to emerge as important advances in asthma treatment, and their effect on IgE and its biomarker role continue to be studied.
Immunology and allergy clinics of North America
Asthma; Biomarkers; Humans; Immunoglobulin E
Asthma; Biomarkers; Immunoglobulin E
Rath N, Raje N, Rosenwasser L. Immunoglobulin E as a Biomarker in Asthma. Immunol Allergy Clin North Am. 2018;38(4):587-597. doi:10.1016/j.iac.2018.06.007